Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;21(10):657-670.
doi: 10.1038/s41579-023-00914-1. Epub 2023 Jun 21.

Prevention, treatment and cure of HIV infection

Affiliations
Review

Prevention, treatment and cure of HIV infection

Raphael J Landovitz et al. Nat Rev Microbiol. 2023 Oct.

Abstract

The development of antiretroviral therapy for the prevention and treatment of HIV infection has been marked by a series of remarkable successes. However, the efforts to develop a vaccine have largely failed, and efforts to discover a cure are only now beginning to gain traction. In this Review, we describe recent progress on all fronts - pre-exposure prophylaxis, vaccines, treatment and cure - and we discuss the unmet needs, both current and in the coming years. We describe the emerging arsenal of drugs, biologics and strategies that will hopefully address these needs. Although HIV research has largely been siloed in the past, this is changing, as the emerging research agenda is marked by multiple cross-discipline synergies and collaborations. As the limitations of antiretroviral drugs as a means to truly end the epidemic are becoming more apparent, there is a great need for continued efforts to develop an effective preventative vaccine and a scalable cure, both of which remain formidable challenges.

PubMed Disclaimer

Similar articles

Cited by

  • Cyclophilin inhibition as a strategy for the treatment of human disease.
    Stauffer WT, Goodman AZ, Gallay PA. Stauffer WT, et al. Front Pharmacol. 2024 Jul 8;15:1417945. doi: 10.3389/fphar.2024.1417945. eCollection 2024. Front Pharmacol. 2024. PMID: 39045055 Free PMC article. Review.
  • Biotech's role in advancing HIV vaccine development.
    Tatoud R, Brander C, Hwang C, Kennelly J, Lu S, O'Neil K, Safrit JT, Benhayoun I, Firmat J, Barriere N. Tatoud R, et al. Emerg Microbes Infect. 2024 Dec;13(1):2384460. doi: 10.1080/22221751.2024.2384460. Epub 2024 Aug 12. Emerg Microbes Infect. 2024. PMID: 39042015 Free PMC article.
  • Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.
    Boomgarden AC, Upadhyay C. Boomgarden AC, et al. Vaccines (Basel). 2025 Jan 31;13(2):148. doi: 10.3390/vaccines13020148. Vaccines (Basel). 2025. PMID: 40006695 Free PMC article. Review.
  • Combination immunotherapy induces post-intervention control of HIV.
    Peluso MJ, Sandel DA, Deitchman AN, Kim SJ, Dalhuisen T, Tummala HP, Tibúrcio R, Zemelko L, Borgo GM, Singh SS, Schwartz K, Deswal M, Williams MC, Hoh R, Shimoda M, Narpala S, Serebryannyy L, Khalili M, Vendrame E, SenGupta D, Whitmore LS, Tisoncik-Go J, Gale M Jr, Koup RA, Mullins JI, Felber BK, Pavlakis GN, Reeves JD, Petropoulos CJ, Glidden DV, Spitzer MH, Gama L, Caskey M, Nussenzweig MC, Chew KW, Henrich TJ, Yukl SA, Cohn LB, Deeks SG, Rutishauser RL. Peluso MJ, et al. Res Sq [Preprint]. 2025 Mar 19:rs.3.rs-6141479. doi: 10.21203/rs.3.rs-6141479/v1. Res Sq. 2025. PMID: 40166020 Free PMC article. Preprint.
  • Phylogenetics and molecular evolution to understand and curb the HIV pandemic.
    Günthard HF, Kusejko K, Kouyos RD. Günthard HF, et al. Nat Rev Microbiol. 2025 Jun 30. doi: 10.1038/s41579-025-01202-w. Online ahead of print. Nat Rev Microbiol. 2025. PMID: 40588586 Review.

References

    1. Landovitz, R. J. et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N. Engl. J. Med. 385, 595–608 (2021). - PubMed - PMC
    1. Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587–2599 (2010). - PubMed - PMC
    1. Joint United Nations Programme on HIV/AIDS. Global HIV and AIDS statistics — 2022 fact sheet. UNAIDS https://www.unaids.org/en/resources/fact-sheet (2022).
    1. Cohen, S. E. et al. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV https://doi.org/10.1016/S2352-3018(18)30288-1 (2018). - DOI - PubMed - PMC
    1. Cohen, S. M., Hu, X., Sweeney, P., Johnson, A. S. & Hall, H. I. HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 US jurisdictions. J. Acquir. Immune Defic. Syndr. 67, 519–527 (2014). - PubMed

MeSH terms